Landscape of AML in 2020 - Marty Tallman, M.D. |
|
|
|
|
|
|
Risk-Adapted Treatment Strategies for AML - Eytan M. Stein, M.D. |
|
|
|
|
|
|
Allogeneic Transplants for AML in 2020 - Robert Soiffer, M.D. |
|
|
|
|
|
|
Landscape of ALL in 2020 - Nitin Jain, M.D. |
|
|
|
|
|
|
MRD in ALL - Wendy Stock, M.D. |
|
|
|
|
|
|
Allogeneic Transplants for ALL in 2020 - Robert Soiffer, M.D. |
|
|
|
|
|
|
Landscape of NHL in 2020 - Anas Younes, M.D. |
|
|
|
|
|
|
Landscape of Hodgkin’s Disease in 2020 - Anas Younes, M.D. |
|
|
|
|
|
|
Landscape of Multiple Myeloma in 2020 - Paul G. Richardson, M.D. |
|
|
|
|
|
|
MRD in Multiple Myeloma (Recorded Video Lecture) - Ola Landgren, M.D., Ph.D. |
|
|
|
|
|
|
Targeted Therapies in Multiple Myeloma - Adam D. Cohen, M.D. |
|
|
|
|
|
|
Wilms’ Tumor Antigen 1 in Multiple Myeloma - Guenther Koehne, M.D., Ph.D. |
|
|
|
|
|
|